"4.6 T\u011Bhotenstv\u00ED a kojen\u00ED"@cs . "T\u011Bhotenstv\u00ED\nPod\u00E1v\u00E1n\u00ED kortikosteroid\u016F b\u0159ez\u00EDm samic\u00EDm bylo p\u0159\u00ED\u010Dinou vzniku abnormalit plodu. V\u00FDznam t\u011Bchto zji\u0161t\u011Bn\u00ED nebyl u lid\u00ED stanoven. P\u0159\u00EDpravek by nem\u011Bl b\u00FDt pod\u00E1v\u00E1n t\u011Bhotn\u00FDm \u017Een\u00E1m, pokud pro to nejsou zvl\u00E1\u0161\u0165 z\u00E1va\u017En\u00E9 d\u016Fvody. Je-li pod\u00E1v\u00E1n\u00ED kortikosteroid\u016F b\u011Bhem t\u011Bhotenstv\u00ED nevyhnuteln\u00E9, m\u011Bl by b\u00FDt preferov\u00E1n inhala\u010Dn\u00ED zp\u016Fsob pod\u00E1n\u00ED, proto\u017Ee inhala\u010Dn\u00ED korikosteroidy maj\u00ED, ve srovn\u00E1n\u00ED s\u00A0rovnocenn\u00FDmi antiastmatick\u00FDmi d\u00E1vkami peror\u00E1ln\u00EDch kortikosteroid\u016F, men\u0161\u00ED syst\u00E9mov\u00FD \u00FA\u010Dinek. \nKojen\u00ED\nInformace o vylu\u010Dov\u00E1n\u00ED budesonidu do mate\u0159sk\u00E9ho ml\u00E9ka nejsou k\u00A0dispozici.\n"@cs . "004.006" . . . . .